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Quantification and parametric imaging of renal cortical blood flow in
vivo based on Patlak graphical analysis. Patlak graphical analysis was
applied to quantify renal cortical blood flow with N-13 ammonia and
dynamic positron emission tomography. Measurements were made in a
swine model of kidney transplantation with a wide range of normal and
abnormal renal blood flows (N = 57 studies) and in 20 healthy human
volunteers (N = 45 studies). Estimates of renal cortical blood flow by
the Patlak method were compared to those from a two-compartment
model for N-13 ammonia. In addition, estimates of renal cortical blood
flow by the N-l3 ammonia PET approach were compared in 10 normal
human volunteers to estimates by the metabolically inert, freely diffus-
ible 0-15 water and a one-compartment model. Patlak graphical analy-
sis estimates of renal cortical blood flow correlated linearly with the
standard two-compartment model in pigs (y = —0.05 + I .Olx, r = 0.99)
and in humans (y = 0.57 + 0.88x, r = 0.93). Estimates of renal cortical
blood flow by 0-15 water in human volunteers were also linearly
correlated with those by N-13 ammonia and the Patlak graphical
analysis (y = 0.71 + 0,84x, r = 0.86). Renal cortical blood flow
estimates were highly reproducible both with N-13 ammonia and 0-15
water measurements in humans. It is concluded that the Patlak graph-
ical analysis with N-l3 ammonia dynamic positron emission tomo-
graphic imaging renders accurate and reproducible estimates of renal
cortical blood flow. Moreover, the graphical analysis approach is 1,000
times faster than the standard model fitting approach and suitable for
generating parametric images of renal blood flow in the clinical setting.
Experimental studies have shown renal blood flow (RBF) to
be heterogeneous under physiologic, ischemic and hyperemic
conditions. This heterogeneity has been demonstrated in animal
models of clinically important conditions such as trauma,
hemorrhage and shock [1]. In addition to the major renal
arteries and veins and their related subbranches, there are
several distinct microvascular networks: the glomerular and the
cortical peritubular microcirculations and microcirculatory sys-
tems that supply and drain the medulla. Methods for measuring
RBF have not been widely applied clinically because of their
invasiveness, technical complexity [2], and limited clinical
availability. Additionally, no clear correlation between the
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distribution of intrarenal blood flow and renal function has been
established [3].
A noninvasive imaging method that provides absolute quan-
titative estimates of RBF per unit mass of renal tissue in
humans is of potential investigative and clinical utility. For
example, abnormalities in RBF resulting from advanced arterial
hypertension, acute cortical necrosis, acute tubular necrosis,
acute rejection of a kidney transplant or cyclosporine toxicity
could potentially be defined more quantitatively and, thus,
objectively.
Positron emission tomography (PET) permits quantitative
volumetric measurements of tissue radioactivity concentrations
from cross sectional images. Chen et al [4] demonstrated in dog
experiments that N-13 ammonia dynamic imaging with PET
provides accurate estimates of renal cortical blood flow
(RCBF). They estimated RCBF by fitting the regional cortical
time-activity curves to a two-compartment model for N-13
ammonia. The estimates by this approach correlated well with
independent measurements by the radiolabeled microsphere
and arterial sample technique.
N-13 ammonia has longer tissue retention times and offers
better count statistics than other PET flow tracers such as 0-15
water. However, retention of N-13 ammonia in tissue may be
sensitive to metabolic alterations. Further, its extraction frac-
tion declines with increasing RBF. Although validated in dogs,
the validity of the N-13 ammonia PET approach for quantifying
RCBF remains to be established in humans. This is because
species related differences may alter the relationship between
the first-pass retention fraction of N-13 ammonia and RBF.
Moreover, quantification of RCBF with the two-compartment
model is tedious, time consuming and, consequently, clinically
impractical. This limitation could be overcome with a more
simple and computationally efficient graphical analysis method
[5, 6].
The purpose of this study was therefore to answer the
following questions: (1) Do the kinetics of N- 13 ammonia in the
kidney satisfy the requirements of Patlak graphical analysis so
that RCBF can be quantified more concisely? If the kinetics are
indeed amenable to the graphical analysis, are the estimates of
RCBF accurate? (2) Can accurate estimates of RCBF be
obtained in humans with N-13 ammonia? and (3) Are such
measurements reproducible?
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Methods
The study design includes studies in animals and in humans.
The animal studies served to test the validity of the graphical
analysis approach over a wide range of RCBF's as well as of
normal and abnormal conditions. The validity of the measure-
ment approach was then tested in humans and compared to an
independent measurement of RCBF with the previously estab-
lished 0-15 water approach [7].
Animals
Ten young adult female Duroc farm pigs (body weight ranging
25 to 30 kg) were studied repeatedly under different experimen-
tal conditions. These included normal-baseline (8 pigs, 8 stud-
ies), acute tubular necrosis in autotransplanted kidneys submit-
ted to different durations of warm ischemia [120 mm, 150 mm,
180 mm (8 pigs, 23 studies)], acute rejection of renal hetero-
transplants (2 pigs, 5 studies), renal hypertrophy (4 pigs, 9
studies) and acute as well as chronic cyclosporine toxicity (6
pigs, 12 studies). Pathologic conditions were confirmed by
biopsy. A total of 57 studies (average 6 studies per animal) with
N-I 3 ammonia and dynamic PET were performed. Details of
renal transplantation of the pig model have been reported by
Yanaga et al [8]. These standardized conditions for hemody-
namics and hydration were applied to all PET studies.
Humans
Twenty healthy human subjects (16 male, 4 female, mean age
29 years, ranging 18 to 54 years) were studied. None had a
history of prior renal disease. Entrance criteria included normal
heart rate, blood pressure, blood cell count, serum creatinine
level, plasma sodium and urine analysis. A total of 45 PET
measurements were performed in the 20 human volunteers. The
first ten subjects had repeat measurements after a 60 minute
delay (to allow for N-13 decay, T112 9.8 mm) to test the
reproducibility of the method. Ten subjects were studied with
both N-13 ammonia and 0-15 water. In this group, five subjects
had repeat 0-15 water studies to evaluate the reproducibility of
the 0-15 water RCBF method. 0-15 water studies were sepa-
rated by 15 minutes (0-15 T112 = 2 mm).
All volunteers were prepared by drinking 500 ml water 60
minutes prior to the study and were instructed to empty the
bladder immediately prior to the PET procedure.
The animal and human studies were approved by the UCLA
Animal Research Committee and the UCLA Human Subject
Protection Committee. Maintenance and care of the pigs was in
compliance with the National Institutes of Health guidelines for
use of laboratory animals. All human subjects signed written
consent forms alter the procedures had been fully explained.
Radiopharmaceuticals
The animals were intravenously injected over 30 seconds
with N-13 ammonia (20 mCi diluted in 2 to 8 ml saline) while
acquisition of the serial transaxial tomographic images was
started. The human volunteers were injected with 20 mCi N-l3
ammonia and (in ten subjects) 30 mCi 0-15 water over 30
seconds into a peripheral vein while acquisition of the serial
transaxial tomographic images was started. Both tracers were
produced and synthesized as reported previously [9, 10].
PET imaging
After obtaining a 30-minute blank scan and a 20-minute
transmission image for photon attenuation correction, both
N-l3 ammonia and 0-15 water emission images were acquired
on a Siemens/CTI Model 93 1/08-12 tomograph. This device
records 15 image planes simultaneously. The axial field of view
is 10.8 cm. Ultrasound guidance was used for adequate position
of the kidneys in the tomograph's field of view. All subjects
were imaged in the supine position.
For N-13 ammonia, the acquisition protocol included twelve
10 second, six 20 second and four 240 second frames in both
humans and animals. For the 0-15 water studies in humans,
twelve 10 second, four 30 second and one 60 second frame were
acquired. Cross sectional images for all studies were recon-
structed employing a Shepp-Logan filter with a cut-off fre-
quency of 0.30 mm', yielding an in plane spatial resolution at
the center of the plane of approximately 10 mm full-width
half-maximum.
Input function
Serial arterial blood samples of 1 ml each were drawn every
10 seconds for the first two minutes alter tracer injection to
measure directly the N-13 ammonia and 0-15 water arterial
input functions. N-13 and 0-15 whole blood activity concentra-
tions in pre-weighed tubes were measured in a well counter. In
addition, for the N-13 ammonia studies, three whole blood
samples (1 ml each) were drawn at 0.65 0.06, 1.35 0.08 and
2 0.05 minutes alter tracer injection to determine the time-
dependent distribution of N-l3 label between ammonia and its
metabolites in the arterial input function as described previ-
ously [11]. These distribution measures were used to correct the
arterial input function for the true amount of N-13 ammonia
delivered to the kidneys.
Conversion factor between image data and well counter data
A cylinder phantom containing Ge-68/Ga-68 solution was
scanned alter each study in order to determine a conversion
factor between image data in units of counts/pixel/sec and well
counter data in units counts/mL/sec. This conversion factor was
derived as follows: a known aliquot from the solution in the
phantom was removed and its activity concentration measured
in a well counter (Turn-Key Microsphere Measurement Sys-
tem, MICRAD). The calibration factor was derived from the
ratio of counts/mllsec measured in the well counter to the
counts/pixel/sec recorded from the cylinder with the PET
scanner.
Data analysis and applied corrections
Circular regions of interest (ROl) were drawn over the renal
cortex using summed images (for example summing the dynam-
ically acquired images one to twelve corresponding to time zero
to two mm post-injection). The ROl's encompassed the entire
transaxial area of the cortex (one region per slice). The central
area, including the renal medulla and collecting system, was
omitted. The ROl's were then copied to the dynamic image set.
Counts/pixel obtained from these ROl's were converted to
counts/pixellmin by normalizing for the acquisition time of each
dynamically acquired image. These values were then converted
to equivalent well counter counts/mllmin using the calibration
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Fig. 1. The two-compartment model for N-13 ammonia RBF quantfi-
cation. The rectangle indicates the kidney region of interest.
dQf(t)Idt, and the trapped N-13 in compartment C2, dQt(t)/dt, in
the kidney are expressed by the following equations:
dQf(t) K1 + RBF
= — Qf(t)+RBF Ca(t) pdt
(eq. 1)
and
dQt(t) K1
= Qf(t) — k2Qt(t) (eq. 2)dt D
where RBF is the renal blood flow in mllmin/g, Qf and Qt are
the total N-13 activity (counts/mi/mm) in compartments C1 and
C2, respectively, K1 the forward rate constant in ml/min/g from
Qf to Qt, k2 the tubular clearance constant in min' from Qt to
the tubular lumen, D the distribution volume in mug of N-13
ammonia within the free space (0.8 mllg [4]), Ca(t) the arterial
activity of N-13 ammonia in counts/minim!, p the specific
gravity of blood (1.05 g/ml) and t the time in minutes. Thus,
RCBF can be calculated by solving these differential equations
describing the two-compartment model and by fitting to the
measured renal tissue time-activity curves. This approach has
been validated for RCBF ranging 1 to 6.5 mllmin/g against
independent microsphere measurements [4].
For the graphical analysis approach the Patlak plot of the
multiple-time renal tissue uptake is defined as the ratio of the
total renal tissue concentration at the times of sampling to the
plasma concentration (Ca) at the respective times (t) versus the
ratio of the arterial plasma concentration-time integral to the
plasma concentration (Ca), as described by equation 7 (listed
below). This equation is derived in the following way: If k2 is
assumed to be 0 and equations 1 and 2 are integrated, then
K1+RBF Ci CtQf(t) = — I Qf(t)dt + RBF p Ca(t)dtVD Jo Jo
(eq. 3)
and
K1 Ct
Qt(t) = I Qf(t)dt (eq. 4)
VDJO
At time t after tracer injection, the N-13 activity concentra-
tion in renal tissue ROl [Qi(t)] equals the sum of the radioac-
tivity of free N-13 ammonia in the freely diffusible pool Qf(t),
the radioactivity of N-13 ammonia metabolites in the bound
pool Qt(t) and the arterial concentration of the radiopharma-
ceutical (AB). This relationship is expressed by
Qi(t) = Qf(t) + Qt(t) + [Vv AB(t)] (eq. 5)
where V,, is the vascular volume and AB the arterial N-13
activity uncorrected for metabolite concentrations. Note the
difference between Ca(t), defined as metabolite corrected N- 13
activity and AB, defined as non-metabo!ite corrected N-l3
activity.
Substituting Qf(t) and Qt(t) in equation 5 by equations 3 and
4, expressing the time integral of Qf(t) for that of Ca(t), and
including the relationship from equation 1 that
Qf(t) = [RBF . VD/(Kl + RBF)] Ca(t) (eq. 6)
factor. All time-activity curves were corrected for dead time of
the scanner [12].
Partial volume effects result in less than 100% recovery of
tissue activity in structures measuring less than about twice the
full-width hall-maximum image resolution value [13]. These
activity losses can be corrected if the recovery coefficient is
known. We employed an approach developed in our laboratory
for the calculation of the recovery coefficients in the animal
studies [14]. This approach is based on cross-sectional profile
fitting analysis. In brief, each circular ROl drawn over the renal
cortex was divided in four subsectors. The estimates of activity
thicknesses, together with four known subsector contour thick-
nesses, were used to derive four subsector recovery coeffi-
cients. These subsector recovery coefficients were then com-
bined into one recovery coefficient for the renal cortical ROl. In
the human studies estimates for the recovery coefficients were
based on ultrasound measurements of the renal cortical thick-
ness.
The true tissue activity concentration in the renal cortex was
calculated as the observed radiotracer concentration divided by
the recovery coefficient.
Patlak graphical analysis for the quantification of RBF
The Patlak approach is a graphical method for estimating the
unidirectional blood-to-renal tissue transfer constant from renal
time-activity uptake data. The approach assumes unidirectional
transport and trapping of N- 13 ammonia from blood into tissue.
The total N-13 activity observed in a region of interest repre-
sents the sum of activities in two functional compartments:
compartment 1 (C1) contains the free N-13 ammonia in renal
tissue and extravascular space, while compartment 2 (C2)
contains the tubular bound or trapped N-13 activity, as shown
in Figure 1. The rate of N-13 change in compartment C1,
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at large t when dQf(t)/dt - 0 and assuming that p equals 1 g/ml
and that AB(t) equals Ca(t) at t  90 seconds, one can obtain a
________________
Patlak equation for calculation of RBF:
_______
J Ca(r)drQf(t) o RBF2 V
= K Ca(t) + (RBF + K1)2 + V, (eq. 7) RBF
where K. is the slope of the straight portion of the Patlak plot
and describes the rate of tracer delivery from arterial blood to
the precursor (freely diffusible) pool times the fraction trapped Fig. 2. The one-compartment model for 0-15 water RBF quantfica-
in the bound pool. K1 can be expressed by tion. The rectangle indicates the kidney region of interest.
K1 = RBF • K1/(RBF + K1) (eq. 8) where Ct is the 0-15 water activity in the ROl in counts/pixel!
mm and V is the distribution volume of water in renal tissue
or within the ROl (ml). The constant p is determined by the
tissue/blood partition coefficient (mug), the specific gravity of
K1 = RBF Er (eq. 9) the kidney and the extraction fraction of 0-15 water in the
when including the retention fraction (Er) for N-13 ammonia in kidney. Solving equation 11 for Ct yields
the kidney
—
RBF t RBF
Ct 
[Er = 1 — 0.83 x e_'3531'], (eq. 10) —v--f eV (t - Ca(r)dr (eq. 12)
derived from dog kidney studies [4]. RBF can then be calcu- Simplifying equation 12 by expressing
lated using equations 9 and 10, by first estimating the slope K1
of the straight portion of the graph, with Qf(t)/Ca(t) as the RBF/PV = k (eq. 13)
vertical y-axis and fCa(1)dT/Ca(t) as the horizontal x-axis [15]. one derivesN-13 ammonia is secreted into the renal tubules. Therefore,
N-13 activity will proceed into the tubular lumen and leave the Ct = Ca(t) ® pke_kt (eq. 14)
region of interest assigned to the renal cortex. Activity concen-
trations will decline, and the assumption of a unidirectional where the asterisk (®) indicates the mathematical operation of
transport or k2 to be zero is no longer valid. Hence, the convolution. Integrating equation 14 for the scan time duration
assumption of a unidirectional transport model for N-13 ammo- t1 to t1÷1 yields
nia is valid only early after tracer accumulation in the renal ti+ i t+ i
cortex. Proper selection of the time period for data analysis j Ctdt =f Ca(t) 0 pke_ktdt (eq. 15)based on the time-activity curves is therefore critical. Conse- tj
quently, only the kinetic data recorded from 40 to 90 seconds
after tracer injection were used in the Patlak approach. In 'Ctdt is measured by PET fort = t1 tot1÷1 for i = 1. . 12 and
addition, effects of including earlier or later recorded kinetic Ca(t) 0 pke_kt is calculated using the one-compartmentmodel and the arterial input function for a given p and renaldata on the Patlak estimates of RCBF were evaluated. blood flow. RCBF was then estimated by using equation 15 to fitII the assumptions are valid, then the fit to the kinetic data the measured renal time-activity curves.
will be linear. The slope represents K, and the y-intercept will Several methods are available to correct for intravasculardepend on the distribution volume (VD), on renal blood flow activity within the tissue ROl before finally estimating RCBF.(RBF), on the forward rate constant from Qf to Qt (K1) and on One employs blood pool images obtained with 0-15 or C-li
the vascular volume (V). Again, the regression line will be carbon monoxide and subtraction of these images from the 0-15
linear only if k2 is indeed 0 for the time of measurement. water images. A second approach adds a third parameter to the
The 0-15 water technique to quantify RBF one-compartment model to estimate the blood pool. In the
The theory for the measurement of blood flow using the inert present study, a third parameter for calculation of the blood
freely diffusible 0-15 water was described for the kidney by pool activity [vascular blood pool in renal tissue (RBV) ob-
Inaba et al [7], and for myocardium by Bergmann et al [16] and served in the analyzed ROl] was added to the 0-15 water model
lida et al [17]. The general principles have been proposed by to correct for intravascular activity within tissue ROl's [20, 21].
Kety [18]. Kuten et al observed a high correlation of RBF This approach was chosen in this study because direct mea-
estimates by 0-15 water and estimates by independent micro- surements of renal intravascular volume with 0-15 carbon
sphere RBF measurements [19]. Figure 2 illustrates the one monoxide renal blood pool imaging would have required an
compartment model used for estimating RBF with 0-15 water. additional imaging procedure, with its inherent compounding of
The following differential equation describes the rate of change errors. Incorporating RBV in equation 15 yields
of 0-15 water within the kidney: ti+
dCt RBF RBF J Ctdt = J Ca(t) 0 pke_ktdt + RBV . Ca(t)(eq. 11) tidt V pV (eq. 16)
Nitzsche et a!: Quantification and parametric imaging of RBF 989
The input function was derived from peripheral arterial blood
sampling. Its inherent problem is the time delay between the
aortic and the peripheral (such as, brachial) peak activity. To
minimize errors potentially introduced by the time delays
between the input function and the tissue response, the peak
activity of the arterial input function was adjusted to the time of
the aortic peak activity. The latter was determined from a
circular ROl (size 6 3 pixel) assigned to the abdominal aorta.
The RCBF value for one kidney was calculated as the
average value for all analyzed ROl per kidney.
Parametric imaging
Parametric images of RCBF using N-l3 ammonia and Patlak
graphical analysis were generated by applying equations 7 and
9 to each pixel.
Statistical analysis
All results are expressed as mean standard deviation (SD).
Linear least-squares regression was performed to correlate
RCBF calculated with the two-compartment model and Patlak
graphical analysis for N-13 ammonia measurements in humans
and animals. For evaluation of mean differences in the repro-
ducibility for N-13 ammonia and 0-15 water RCBF studies as
well as differences between N-l3 ammonia and 0-15 water
RCBF measurements, the paired t-test was used. A P value <
0.05 was considered significant.
Results
N-13 ammonia renal imaging and Pat/ak graphical analysis
N-13 ammonia yielded high quality cross-sectional images of
the kidneys with PET imaging. The image quality was pre-
served even when RCBF was markedly altered as was the case
in the pig experiments (Fig. 3). As shown in Figure 4, the Patlak
plots of the time-activity curves for all analyzed ROl were
consistently linear for the selected sampling times. If earlier
(such as 20 to 30 seconds post-injection) recorded renal tissue
points were included for the Patlak graphical analysis, the
calculated RCBF values did not correlate as well with model
fitting results, because that part of the data is not expected to be
linear. In addition, if more (such as >90 seconds post-injection)
renal tissue points were included, the curve of the Patlak plot
became nonlinear, indicating that the definition (such as the
tubular clearance k2 is negligible) for Patlak graphical analysis
may no longer be satisfied. For k2 ranging from 0 min' to 0.2
min1 after 110 seconds post-injection the change of the RCBF
estimates was less than 5%. It was similar at both high and low
RCBF values.
Comparison of Patlak graphical analysis and the two-
compartment model
Animal studies. Estimates of RCBF derived by the Patlak
graphical analysis correlated linearly with estimates obtained
by the two-compartment model fitting (y = —0.05 + 1 .Olx, r =
0.99) as illustrated in Figure 5. RCBF ranged 0.18 to 6.35
ml!min!g.
Human studies. As shown in Figure 6, there is a linear
correlation between estimates of RCBF by Patlak graphical
analysis and those by the two-compartment model in normal
human volunteers. The slope of the regression line and the
correlation coefficient are slightly less than in the pig studies (y
= 0.57 + 0.88x, r = 0.93). One reproducibility study with N-l3
ammonia was not performed because the isotope production
failed. Therefore, the results reported above refer to 29 N-13
ammonia dynamic PET studies. Estimates of normal RCBF by
the N-13 ammonia PET approach averaged 4.64 0.48 ml!
min!g for Patlak graphical analysis and 4.61 0.51 mL'min/g for
model fitting.
0-15 water studies
0-15 water dynamic PET renal images compared to N-13
ammonia renal PET images have lower image quality, such as
lower kidney to background ratio. However, both kidneys are
depicted clearly in normal human volunteers (Fig. 7). Estimates
of normal RCBF by the 0-15 water approach averaged 4.70
0.28 mUminlg. The added third parameter to the one-compart-
ment model for 0-15 water renal studies produced estimates of
the blood pool present in the arterial bed in the analyzed
cortical tissue ROl. The observed value of this parameter was
0.16 0.11 mug.
Comparison of RCBF estimates derived from N-13 ammonia
and 0-15 water studies
As shown in Figure 8, the estimates of RCBF for both
radiopharmaceuticals in human normals were linearly corre-
lated. The differences between the N-13 ammonia and the 0-15
water RCBF estimates were statistically insignificant. A P value
of 0.48 for Patlak graphical analysis RCBF estimates and a P
value of 0.23 for the two-compartment model fitting RCBF
estimates compared to 0-15 water RCBF estimates were ob-
served.
Reproducibility of RCBF measurements
Heart rate and blood pressure remained stable in all subjects
during the PET measurements. Repeat measurements of RCBF
with N-l3 ammonia and dynamic PET in nine volunteers
revealed for Patlak graphical analysis individual interstudy
differences of 0.31 0.18 mllmin/g or 6.6% 3.7% (P = 0.91)
and for model fitting 0.22 0.15 ml/min/g or 5.0% 3.4%(P =
0.62). Absolute individual interstudy differences for 0-15 water
measurements in five volunteers were 0.11 0.07 ml/min/g or
2.2% 1.3% (P = 0.12). The interstudy differences of the
RCBF estimates within each individual approach were insignif-
icant.
N-13 ammonia metabolites
The results of N-13 ammonia metabolite measurements are
shown in Table 1. The mean amount of N- 13 labeled ammonia
metabolites as fraction of the total N-13 activity at two minutes
post injection was 7% 5% for human normals while in pigs it
was 10.5% 2%.
Thickness of the renal cortex
Circumferential profile fitting analysis revealed the following
average estimates for renal cortical thickness in the pig exper-
iments: 11.8 0.7 mm for normal kidneys, 13.9 1.2 mm for
acute tubular necrosis, 14.0 0.5 mm for acute rejection, 13.5
1.4 mm for renal hypertrophy and 11.6 0.5 mm for
cyclosporine toxicity. These results indicate an increasing renal
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Fig. 3. N-13 ammonia cross sectional images of the kidneys. (a) Summed dynamic PET images [0 to 2 mm post-injection (p.i.)J of normal kidneys
in a healthy human volunteer (pO4O92). N-13 ammonia indicates normal RCBF, left: 4.76 mi/minig, right: 4.71 ml/min/g. (b) Summed dynamic PET
images (0 to 2 mm p.i.) of a transplant kidney in acute rejection in a pig (A00577). N-13 ammonia indicates markedly reduced RCBF: 0.55 ml/min/g,
as well as flow defects within the kidney. (c) Summed dynamic PET images (0 to 2 mm p.i.) of a transplant kidney in acute tubular necrosis in a
pig (A00534). N-13 ammonia indicates markedly reduced RCBF: 0.88 mI/min/g.
cortical thickness caused by renal parenchyma swelling induced sistent in acute rejection, at least for the time period of the
by ischemia in acute tubular necrosis and acute rejection. This study. The latter trend, resulting from cellular hypertrophy,
increase was only transient in acute tubular necrosis but per- was also observed for renal hypertrophy following unilateral
Cranial
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nephrectomy. Cyclosporine toxicity did not affect renal cortex
thickness. For the normal human kidneys a renal cortical
thickness of 12.0 0.7 mm was calculated. It was similar to
ultrasound estimates, 11.5 1.0 mm.
Parametric imaging
As shown in Figure 9, parametric images of RCBF contain
less noise and therefore an improved kidney to background
ratio as compared to dynamic renal images.
Computation time
The computation time for the Patlak approach to estimate
RCBF in a 15 plane dynamic study is two minutes. This is
—50% faster as compared to approximately four to five minutes
for the model fitting method.
Discussion
The results of this study indicate that the kinetics of N- 13
ammonia in the kidney following intravenous injection satisfy
the requirements of Patlak graphical analysis. Therefore, Patlak
graphical analysis can be applied to quantify RCBF. Moreover,
Patlak graphical analysis produces RCBF estimates comparable
to those obtained with the two-compartment model method for
N-l3 ammonia. Further, the excellent agreement of the N-13
ammonia estimates of RCBF with those by the metabolically
inert and less flow dependent 0-15 water method supports the
validity of the N-13 ammonia technique in humans, which, as
demonstrated by repeat measurements, is highly reproducible.
Comparison of RCBF estimates derived from Patlak
graphical analysis and the two-compartment model for N-13
ammonia
The slightly better correlation between Patlak graphical anal-
ysis and model fitting in the pig experiments (Fig. 5) as
compared to the correlation in the human studies (Fig. 6) may
have been due to the narrow range of RCBF's in humans and
better count statistics in the animal experiments.
Quantfi cation of RCBF with dynamic PET and N-13
ammonia or 0-15 water and its limitations in the present
study
The PET technique for measurements of RBF has been
successfully employed by several groups [4, 7, 22, 23] as well as
in the present study. For renal PET imaging in humans, only
0-15 water and N-13 ammonia have been used. We prefer N-13
ammonia over 0-15 water for RBF imaging because of the
better count statistics and therefore better image quality. An
additional advantage is the suitability of N-l3 ammonia for
generating parametric images of RCBF based on Patlak graph-
ical analysis. Studies from other laboratories using the external
detector or PET techniques have reported the feasibility of
rubidium-82 as indicator of RBF in dogs. RBF ranged 0.2 to 5.5
mllmin/g [22—24]. The validity of rubidium-82 as RBF agent in
humans has not yet been confirmed. Despite the present study
one group recently employed 0-15 water for dynamic PET
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Fig. 4. The Patlak graph. (A) Plot of a Patlak graph from a study in a healthy human volunteer (P04092). Filled circles are the data points, while
the straight line is a linear fit to the data from 40 to 90 sec p.i., RCBF: 4.65 ml/min/g. (B) Corresponding plot of the fit (0 to 2 mm p.i.) of the
two-compartment model to the renal time-activity curve (dashed line), RCBF: 4.72 mllmin/g. Solid line represents the time-activity curve for the
arterial input function. (C) Plot of a Patlak graph from a study in a pig (A00577) for evaluation of acute rejection. Data from 40 to 90 seconds p.i.
are linearly fitted. RCBF is markedly altered: 0,51 ml/min/g, compared to normal RCBF in pigs: 3.20 ml/min/g. (D) Corresponding plot of the fit
(0 to 2 mm p.i.) of the two-compartment model to the renal time-activity curve (dashed line). Solid line represents time-activity curve for the arterial
input function. RCBF: 0.55 mllminlg. (E) Plot of a Patlak graph from a study in a pig (A00534) for evaluation of acute tubular necrosis. Data from
40 to 90 sec p.i. are linearly fitted. RCBF is markedly altered: 0.85 mllminlg. (F) Corresponding plot of the fit (0 to 2 mm p.i.) of the
two-compartment model to the renal time-activity curve (dashed line). Solid line represents time-activity curve for the arterial input function.
RCBF: 0.87 ml/minlg.
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Fig. 5. Correlation of Patlak graphical analysis and the two-compart-
ment model for RCBF quantffication in the pig studies (N = 10pigs, N
= 59 studies, N = 71 kidneys). y = —0.05 + l.Olx, r = 0.99.
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Fig. 6. Correlation of Patlak graphical analysis and the two-compart-
ment model for RCBF quant{fication in 20 normal human volunteers (N
= 29 studies, N = 58 kidneys). y = 0.57 + 0.88x, r = 0.94.
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measurements of RBF in eight human subjects [7]. The advan-
tage of 0-15 water as RBF agent is that it is metabolically inert
and completely extracted in renal tissue. In contrast, N-13
ammonia is not metabolically inert and its retention fraction
declines as RBF increases above the normal range [4]. For the
latter reason it is necessary to include the relationship between
RBF and retention fraction. This relationship is mathematically
expressed by equations 9 and 10. Both equations are incorpo-
rated in the Patlak and the two-compartment model fitting
approach. Its limitation is the derivation from animal studies
because microsphere studies cannot be performed in humans.
However, the good agreement between RCBF estimates ob-
tained by both, the 0-15 water and N-13 ammonia PET ap-
Fig. 7. 0-15 water cross-sectional images of the
kidneys and a plot of an one-compartment mode/fitting
graph. (A) Summed dynamic PET images of the kidneys
of a dynamic 0-15 water study in a healthy human
volunteer (P04092). (B) Plot of the fit (dashed line, 0-2
mm p.i.) of the one-compartment model to the renal
time-activity curve. Solid line represents the time-
activity curve for the arterial input function, RCBF:
4.85 ml/min/g.
proach provides evidence of the validity of N-13 ammonia as
RBF agent in humans. For the clinical applications of N-13
ammonia, one is most likely referred to decreased or normal
RBF rather than the evaluation of the hyperemic RBF re-
sponse. For both conditions, N-13 ammonia provided high
quality images and comparable RCBF estimates even if RCBF
was markedly altered.
A potential disadvantage of the 0-15 water technique is the
need for blood volume correction for each individual RBF
study. Inaba et al [7] utilized 0-15 carbon monoxide PET
imaging for blood volume correction. The fraction of radioac-
tivity due to 0-15 water in the vascular spaces was removed by
subtracting 0-15 carbon monoxide images from corresponding
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Fig. 8. Correlation of estimat 's of RCBF by (A) Patlak graphical
analysis (y = 0.71 + 0.84x, r = 0.86) and (B) the two-compartment
model for N-13 ammonia dynamic PET (y = —0.09 + 1.03x, r = 0.91)
compared to estimates of the one-compartment model fitting for 0-15
water.
0-15 water emission images. Inaccuracies in the subtraction
process may cause errors in the estimation of RBF [25]. For the
present study, a third parameter was added to the one-compart-
ment model for 0-15 water in order to correct for blood volume
effects. Including the blood volume term in the fitting procedure
was found by others to be superior to the subtraction method,
both in terms of accuracy and precision [21]. The correction
approach may also have contributed to the good agreement
between N-13 ammonia and 0-15 water RCBF estimates ob-
served in this study.
N-13 ammonia metabolites
Accurate quantification of RCBF based on N-13 ammonia
dynamic PET studies requires appropriate correction for the
Time post-p.i. mm
Percentage of tru
(mean
e N-13 ammonia
SD)
Humans Pigs
0.66 99.24 0.66 99.28 0.31
1.33 97.75 1.73 96.78 1.14
2.00 93.07 5.22 89.52 1.82
contamination of the arterial input function by N-13 labeled
ammonia metabolites. The observed percentage of non-ammo-
nia metabolites of 7% 5% in our normal humans is compara-
ble to the reported percentage (6% 3%) obtained from venous
whole blood sampling for the respective time period in human
normals [261. While serial arterial blood sampling for measure-
ments of N-i 3 labeled ammonia metabolites adds complexity to
human clinical RBF studies, alternative methods to minimize
invasiveness and inaccuracy are of potential interest. The
independent observation of comparable N-l3 labeled ammonia
metabolite blood concentrations by two study groups suggests
two methods. The interpolation of N-13 labeled metabolite
concentrations measured in venous blood samples represents
one method. Routine computational incorporation of reported
metabolite concentrations may be an alternative method. Use
of an uncorrected arterial input function may cause some
underestimation of RBF. Based on the data in this study, this
underestimation would amount to 5.1% 0.9%, which if
consistent, may also be acceptable in the clinical setting and
render the approach rather noninvasive. For animal studies,
observations from the same group [26] as well as in this study
indicate that there are species differences in the blood concen-
trations of N-13 labeled ammonia metabolites within the two
minutes post injection time period, such as 19% 16% for dogs
and 10.5% 2% for pigs. These observations suggest the need
for metabolite correction when N- 13 ammonia is utilized for
RBF studies in animals.
Minimization of invasiveness to obtain the input function
Determination of the arterial input function from serial blood
samples, as performed in this study, adds complexity to routine
clinical procedures. However, alternative methods include
sampling from the arterial part of an arterio-venous shunt or
dynamic PET measurements of the abdominal aortic activity for
the non-invasive determination of the arterial input function
[27].
Recove,y coefficients for renal cortex
Corrections for partial-volume effects (such as renal cortex
recovery coefficient) are relatively straightforward in the nor-
mal human kidney where cortex and medulla are identifiable
sonographically. However, in human kidney transplants, ana-
tomical measurements based on ultrasound do not provide
appropriate measures of the renal cortex thickness. In such
conditions, use of cross-sectional profile fitting analysis or
constant recovery coefficients may be preferable. The results
A Table 1. The percentage of true N-13 ammonia over a time interval
of two minutes as determined from serial arterial blood sampling after
peripheral intravenous injection (p.i.) of N-l3 ammonia
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Fig. 9. Parametric cross-sectional image of
N-13 ammonia indicated RCBF, generated
from a study in a healthy human volunteer
(P04092).
Table 2. Comparison between normal RCBF values produced by
PET and the Xenon-133 washout method
RCBF
Method Approach mI/minig
PET N-13 ammonia Patlak graphical analysis 4.64 0.48
PET N-13 ammonia Two-compartment
model
4.61 0.51
PET 0-15 water One-compartment model 4.70 0.28
Xenon-133 washout 4.10 0.90 [28]
Xenon-133 washout 5.38 0.86 [29]
based on pig experiments indicate the need for such a compro-
mise for non-physiological conditions like acute tubular necro-
sis, acute rejection or renal hypertrophy, when accurate ana-
tomical measurements for the object size are not available. The
recovery coefficient can differ significantly (for example, nor-
mal cortex value of —0.65 to —0.75 compared to acute tubular
necrosis value of —0.75 to —0.85). Since this variability affects
Patlak graphical analysis and model fitting results in the same
way, this is not a limitation specific to the Patlak method.
Parametric images of N-13 ammonia indicated RCBF
Parametric PET imaging of RCBF is an advantageous ap-
proach particularly for the clinical setting. It provides dynami-
cally acquired geographic information about RCBF compressed
in a single renal PET image. In addition, the unspecific back-
ground noise is suppressed rendering improved image quality
compared to dynamic renal PET images.
RCBF in human normals measured by dynamic PET
compared to the Xenon-133 washout method
In the renal cortex blood flow averages 4 to 6 ml/min/g as
indicated from measurements in different animal species and
human studies [28]. The RCBF values measured with PET in
human normals in this study are comparable to those by the
Xenon-133 washout method [29, 30] listed in Table 2. The
slightly higher RCBF values reported by Ladefoged and Peder-
son [30] may be explained by the small age range of the
volunteers and possible differences in the sodium balance.
Clinical RCBF studies based on dynamic PET
PET offers assessment of RBF without urine collection, as
required in standard clearance techniques. Therefore, PET is
applicable to the oliguric state. RBF can be measured noninva-
sively within a reasonable time as for example 30 minutes. RBF
analysis can be performed on data acquired dynamically over
three to five minutes. Repeat measurements can be performed
within a short time period. Information about compartmental
RBF is provided, not obtained from gamma camera renal
studies or clearance methods. Finally, the radiotracer can be
administered intravenously.
Conclusion
Patlak graphical analysis applied to N-13 ammonia dynamic
PET for quantifying RCBF in vivo in humans is an accurate,
reproducible and computationally fast method for investigative
and clinical applications. N-l3 ammonia is a valid RCBF
indicator in humans compared to the 0-15 water technique.
Quantification of RCBF with dynamic PET is highly reproduc-
ible. Parametric imaging of N-l3 ammonia indicated RCBF is an
advanced imaging approach for the clinical setting.
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